| Price | 555.00p on 20-02-2026 at 19:10:04 |
|---|---|
| Change | 0.00p 0% |
| Buy | 580.00p |
| Sell | 530.00p |
| Last Trade: | Sell 200.00 at 550.00p |
| Day's Volume: | 1,163 |
| Last Close: | 555.00p |
| Open: | 555.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 550.00p - 555.00p |
| 52wk Range: | 550.00p - 1,200.00p |
| Market Capitalisation: | £85.94m |
| VWAP: | 555.03852p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 200 | 550.00p | Ordinary |
16:05:03 - 20-Feb-26 |
| Buy* | 18 | 557.40p | Ordinary |
11:00:23 - 20-Feb-26 |
| Buy* | 89 | 557.40p | Ordinary |
11:00:22 - 20-Feb-26 |
| Sell* | 200 | 550.00p | Uncrossing Trade |
11:00:22 - 20-Feb-26 |
| Buy* | 356 | 558.00p | Ordinary |
08:03:33 - 20-Feb-26 |
| Buy* | 152 | 558.88p | Ordinary |
08:49:04 - 19-Feb-26 |
| Buy* | 1 | 580.00p | SI Trade |
16:29:16 - 18-Feb-26 |
| Unknown* | 0 | 580.00p | SI Trade |
16:29:16 - 18-Feb-26 |
| Unknown* | 2,452 | 530.00p | Negotiated Trade |
16:29:14 - 18-Feb-26 |
| Sell* | 600 | 550.00p | Ordinary |
16:28:40 - 18-Feb-26 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Feb 2026 7:00 am | PRN | Director Dealing |
| 11th Feb 2026 3:58 pm | PRN | Director Dealing |
| 10th Feb 2026 7:00 am | PRN | Leadership Changes |
| 27th Oct 2025 7:00 am | PRN | Synthetic opDNA® utilised in Phase I/II US clinical trials |
| 10th Oct 2025 11:30 am | PRN | Result of Extraordinary General Meeting |
| 30th Sep 2025 4:20 pm | PRN | Director Dealing |
| 29th Sep 2025 7:00 am | PRN | Half-year Report |
| 22nd Jul 2025 7:00 am | PRN | Employee Long Term Incentive Plan and Issue of Equity |
| 8th Jul 2025 10:30 am | PRN | Director Appointment, Board Change |
| 3rd Jul 2025 7:00 am | PRN | Holding(s) in Company |
